Xiangxue Pharmaceutical Co.,Ltd. Financials

Market Capitalization CN¥5.53 Billion as of July 1, 2025

Valuations Metrics as of Jul. 5, 2025

Trailing PE	-6.44
Forward PE	28.86
Price to Sales TTM	CN¥3.24
Price to Book MRQ	CN¥5.84
Enterprise to Revenue	4.79
Enterprise to EBITDA	-136.57

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	-53.23%
Operating Margin	-0.74%
Return on Assets TTM	-2.19%
Return on Equity TTM	-50.10%

Income Statement

Revenue TTM	CN¥1,710,809,600
Revenue per Share TTM	CN¥2.63
Quarterly Revenue Growth	-26.00%
Gross Profit TTM	CN¥327,245,760
EBITDA	CN¥22,700,633
Net Income to Common TTM	CN¥-910,632,960
Diluted EPS TTM	CN¥-1.38
Quarterly Earnings Growth YoY	-25.99%

Balance Sheet

Total Cash MRQ	CN¥57,521,160
Total Cash per Share MRQ	CN¥0.09
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	165.66
Current Ratio MRQ	0.28
Book Value per Share MRQ	CN¥1.43

Cash Flow

Operating Cash Flow TTM	CN¥-90,099,416
Levered Free Cash Flow TTM	CN¥502,753,088

300147 Stock Info as of Jul. 5, 2025

Stock Statistics

Shares Outstanding	661,279,045
Float Shares	492,984,904
Avg 10 Volume	14,370,449
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	27.17%
% Held by Institutions	1.98%

Stock Price Summary

Beta	0.49
Fifty Two Week Low	CN¥3.21
Fifty Two Week High	CN¥16.49
Fifty Two Week Change	57.23%
Day 50 MA	CN¥7.87
Day 200 MA	CN¥9.43

Dividends and Splits

Forward Annual Dividend Rate	CN¥0.18
Forward Annual Dividend Yield	2.20%
Trailing Annual Dividend Rate	CN¥0.05
Trailing Annual Dividend Yield	0.55%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date	2020-06-23
Last Split Factor
Last Split Date	2014-07-14